MercoPress, en Español
Get our news on your inbox! Suscribe x
Montevideo, August 4th 2020 - 17:31 UTC
Chinese drug company Sinopharm and Parana state have agreed to launch the fourth major COVID-19 vaccine trial in Brazil and will seek regulatory approval in the next two weeks, the Brazilian partners said on Wednesday.
Get our news on your inbox!